ANTISICKLING EFFECTS OF 2,3-DIPHOSPHOGLYCERATE DEPLETION

被引:49
|
作者
POILLON, WN
KIM, BC
LABOTKA, RJ
HICKS, CU
KARK, JA
机构
[1] HOWARD UNIV,COLL MED,CTR SICKLE CELL DIS,WASHINGTON,DC 20059
[2] HOWARD UNIV,COLL MED,DEPT PEDIAT & CHILD HLTH,WASHINGTON,DC 20059
[3] WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DEPT HEMATOL,DIV MED,WASHINGTON,DC 20307
关键词
D O I
10.1182/blood.V85.11.3289.bloodjournal85113289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevation of 2,3-bisphosphoglycerate (2,3-DPG) in sickle erythrocytes (SS RBCs) and concomitant acidification of the cell interior promote polymerization by decreasing the solubility (c(sat)) of deoxyhemoglobin S. The antisickling effect of 2,3-DPG depletion was evaluated after activation of the 2,3-DPG phosphatase activity of bisphosphoglycerate mutase by glycolate-2-phosphate, leading to rapid loss of intracellular 2,3-DPG. To ensure its maximal reduction in a physiologic medium, isosmotic CO2/bicarbonate-buffered saline, pH 7.0, was used. Substitution of K+ for Na+ as the major extracellular cation suppressed K:Cl cotransport, prevented cell shrinkage, and allowed demonstration of the full antisickling effect of 2,3-DPG depletion. The modest effect on solubility per seof removing intraerythrocytic 2,3-DPG (Delta c(sat) = 1.6 g/dL) was amplified into a much larger antisickling effect by interaction with three other cellular variables affecting solubility and polymer content (intracellular pH, O-2 saturation, and mean cell hemoglobin concentration). Acting in concert, these four antisickling effects (three solubilizing, one osmotic) reduced polymer fraction of glycolate-treated SS RBCs by 32% to 63%, with a concomitant decrease in sickling of 46% to 95% at the nominal pO(2) of the microcirculation (20 mm Hg). A decrement in sickling of this magnitude should significantly ameliorate the vasoocclusive severity of sickle cell disease. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:3289 / 3296
页数:8
相关论文
共 50 条
  • [1] RELATIONSHIP OF 2,3-DIPHOSPHOGLYCERATE AND 2,3-DIPHOSPHOGLYCERATE MUTASE IN VARIOUS MAMMALS
    CHEMTOB, S
    GIBB, W
    BARD, H
    BIOLOGY OF THE NEONATE, 1980, 38 (1-2): : 36 - 39
  • [2] MICRODETERMINATION OF 2,3-DIPHOSPHOGLYCERATE
    SASAKI, R
    IKURA, K
    SUGIMOTO, E
    CHIBA, H
    ANALYTICAL BIOCHEMISTRY, 1974, 61 (01) : 43 - 47
  • [3] ENZYMATIC DEGRADATION OF CYCLIC 2,3-DIPHOSPHOGLYCERATE TO 2,3-DIPHOSPHOGLYCERATE IN METHANOBACTERIUM-THERMOAUTOTROPHICUM
    SASTRY, MVK
    ROBERTSON, DE
    MOYNIHAN, JA
    ROBERTS, MF
    BIOCHEMISTRY, 1992, 31 (11) : 2926 - 2935
  • [4] EFFECTS OF 2,3-DIPHOSPHOGLYCERATE ON KINETICS OF BOHR EFFECT
    ELIOT, RS
    SALHANY, JM
    MIZUKAMI, H
    CIRCULATION, 1970, 42 (04) : I151 - &
  • [5] PROTECTION OF METHEMOGLOBINEMIA BY 2,3-DIPHOSPHOGLYCERATE
    WANG, X
    METCALF, WK
    CLINICAL RESEARCH, 1989, 37 (04): : A978 - A978
  • [6] 2,3-DIPHOSPHOGLYCERATE DURING EXERCISE
    BOSWART, J
    KUTA, I
    LISY, Z
    KOSTIUK, P
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 1980, 43 (03) : 193 - 199
  • [7] ERYTHROCYTE 2,3-DIPHOSPHOGLYCERATE IN POLYCYTHEMIAS
    VILLEGAS, A
    ALVAREZSALA, JL
    ESPINOS, D
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1982, 29 (01): : 94 - 95
  • [8] BINDING OF 2,3-DIPHOSPHOGLYCERATE TO OXYHEMOGLOBIN
    LUQUE, J
    DIEDERICH, D
    GRISOLIA, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1969, 36 (06) : 1019 - +
  • [9] THE BIOLUMINESCENT DETERMINATION OF 2,3-DIPHOSPHOGLYCERATE
    KARP, MT
    RAUNIO, RP
    LOVGREN, TNE
    ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS, 1983, 16 (07): : 515 - 524
  • [10] 2,3-DIPHOSPHOGLYCERATE IN ACUTE ASTHMA
    GALLAGHER, PJ
    JOURNAL OF CLINICAL PATHOLOGY, 1971, 24 (06) : 518 - +